Following administration of sodium nitroprusside (SNP), arterial pressure generally returns to preinfusion values in 5-15 min [1] . This is presumed to result from intravascular degradation of the drug [2] . However, we found that when the compound was incubated in vitro with fresh human blood at a concentration of 5 |imol litre" 1 it had a decomposition half-life (7J) of 27 min [2], while in rat blood a greater concentration (67 umol litre" 1 ) [3] gave a 7j of 43 min. Thus the apparently shoner 7} in patients may be caused by much smaller SNP concentrations. However, no blood concentrations in humans have been reported, apart from those following long-term infusion [4]. Using our assay described previously [2], we therefore measured SNP in the plasma of patients at the end of a short-term infusion, and related the decrease to changes in arterial pressure and blood HCN concentrations.
Following administration of sodium nitroprusside (SNP), arterial pressure generally returns to preinfusion values in 5-15 min [1] . This is presumed to result from intravascular degradation of the drug [2] . However, we found that when the compound was incubated in vitro with fresh human blood at a concentration of 5 |imol litre" 1 it had a decomposition half-life (7J) of 27 min [2] , while in rat blood a greater concentration (67 umol litre" 1 ) [3] gave a 7j of 43 min. Thus the apparently shoner 7} in patients may be caused by much smaller SNP concentrations. However, no blood concentrations in humans have been reported, apart from those following long-term infusion [4] . Using our assay described previously [2] , we therefore measured SNP in the plasma of patients at the end of a short-term infusion, and related the decrease to changes in arterial pressure and blood HCN concentrations.
PATIENTS AND METHODS
Twenty patients undergoing orthopaedic or plastic surgery requiring SNP-induced hypotension gave informed consent. Their ages were 21-68 yr; 12 were males and six were smokers (table I) .
A 1 % solution of SNP in 5 % glucose was infused from a foil-wrapped syringe actuated by a digital pump (Treonic IP3; Vickers Medical Ltd), to maintain mean arterial pressure (MAP) at 50-60 mm Hg throughout surgery. Infusion times were 21-139 min and SNP doses 0.07-0.52 mg kg" 1 (table I) . Arterial pressure was monitored directly from the radial artery during the infusion and for at least 15 min thereafter.
Arterial blood samples (15-20 ml) were taken into ice-cold, foil-wrapped, heparinized syringes, before and at the immediate end of infusion, and 1, 2, 5 and 15 min later. In eight patients, two additional samples were taken at 3.5 and 10 min after the infusion. Following collection, the samples were placed in ice and water, and promptly transported to and processed in the laboratory.
Duplicate packed cell volumes were determined by microhaematocrit, and the bulk of each sample was centrifuged immediately for 10 min at 2000 £ and 0 °C. As described previously [2] ,.a measured amount of the separated plasma was added to four volumes of acetate buffer 0.2 mol litre" 1 pH 3.5 in a foil-wrapped tube. Any free HCN present in the plasma was first transferred to sodium hydroxide (NaOH) with a stream of nitrogen 750 ml min" 1 for 90 min, then any remaining intact SNP was decomposed by exposure of the plasma-buffer mixture to ultraviolet light (u.v.), from a 20-W Mazdafluor "Black light" tube, whilst continuing nitrogen aeration for a further 2 h and trapping the liberated HCN in fresh NaOH. A separate aliquot of plasma was deproteinized with 5% trichloroacetic acid (TCA) and used for the determination of thiocyanate (SCN~). The salinewashed red cells were haemolysed, mixed with three volumes of 10 % TCA and the free HCN also transferred to NaOH. The isolated HCN and plasma SCN" were measured by an autoanalytical method [5] . The serial SNP concentrations for each patient were analysed graphically and Tj calculated in each case using the STRIPE program [6] on a BBC microcomputer. In this program the data are fitted by a one-or two-compartment model , (i.e. one or two exponentials). The choice of model was made using Akaike's Information : Criterion [7] : as with most linear regression programs, the data are weighted equally. Linear correlations between the various measures were sought using the Minitab statistics package [8] .
RESULTS
The immediate post-infusion plasma SNP, plasma HCN and RBC HCN concentrations, together with the increase in plasma SCN" concentration over the period of infusion, are shown in table II. A good correlation was found between plasma SNP concentrations and red cell and plasma HCN values, SNP dose and dose rate, as reflected in the linear correlations (dose rate vs plasma SNP: r = 0.66, P< 0.001; vs RBC HCN: r = 0.55; vs plasma HCN: r = 0.61, P < 0.01). The increases in plasma SCN" were small and with a more consistent relation to infusion time (r = 0.63, P < 0.01) than to the infused dose of SNP (r = 0.30, P> 0.1).
The clear relationship between MAP values and plasma SNP concentrations, expressed as a percentage of those at the termination of infusion, is illustrated both by the plots of mean values ( fig.  1 ) and by the correlation (r = -0.99, P < 0.001) between MAP and the log mean SNP concentration ( fig. 2) .
The changes in the mean values of plasma HCN, RBC HCN and plasma SCN~ concentrations and those of plasma SNP concentrations during the 15 min following infusion, are illustrated in figure 3 . The decrease in mean plasma HCN closely followed that of the plasma SNP (r = 0.95, P < 0.001). Although mean packed cell volumes at each sample time decreased over the course of infusion (mean (SD) 39.6 (4.7)% before infusion, 36.1 (4.6)% after infusion), in no patient was there a significant change during the following 15 min (35.5(4.5)% at 1 min; 36 (4.9)% at 15 min) and thus plasma concentrations of SNP and HCN were unlikely to have been influenced by changes in volume during this period. The mean SNP concentrations plotted on a log scale against time ( fig. 4) suggest that the in vivo decay of SNP probably takes the form of a biexponential curve. The biphasic nature of the decay was confirmed; individual values for the half-lives of each phase (Tf, Tf) determined by the STRIPE computer program [6] (table II) . The initial rate of decay was rapid, so that at 15 min plasma SNP concentrations were, in most cases, near to the lower limit of the assay (7.7 (4.5) ug litre" 1 ). Few other measurements of blood concentrations of SNP have been reported. Rodkey and Collinson [9] , measuring plasma SNP by the quantitative release of HCN in a reaction with cysteine, found concentrations of approximately 3.7 mg litre" 1 at the end of infusion in a baboon receiving 3.01 mg kg" 1 over the course of 1 h. They also found that SNP was still present in the animal's blood 3 h after infusion ended.
Desprez and colleagues [4] measured plasma SNP colorimetrically in patients receiving longterm infusions for malignant hypertension and reported surprisingly high prolonged concentrations of 15, 24 and 28 mg litre" 1 at 3.5,19.5 and 5 h, respectively, after infusion.
After infusion, plasma HCN concentrations decline rapidly as HCN passes readily into the erythrocytes [10] and undergoes detoxication, producing an increase in plasma SCN" (fig. 3) . If, as has been assumed, plasma HCN results from the breakdown of SNP, its decline should be related to the post-infusion reduction in plasma SNP. Our data show a good correlation between the mean plasma concentrations of HCN and the mean plasma concentrations of SNP after infusion (r = 0.95, P< 0.001).
Our results confirm that the rapid increase in arterial pressure following infusion is a direct result of the more rapid decay of the drug in vivo than in vitro (mean MAP vs log SNP concentration, r = -0.993). They also indicate either that SNP degradation is more rapid in vivo or that there is an additional mechanism for its removal from the circulation. The latter may be true, as our data suggest that its decay is probably biphasic ( fig. 4 ) with a mean Tf of 0.9 (0.6) min and a mean Tf of 14 (12) min (table II) .
Hbbel and Raithelhuber [11] gave bolus doses of SNP 0.4 mg kg" 1 and 6.25 mg kg" 1 to rats and showed monophasic Tj of 2 and 27.5 min, respectively. Kreye and Reske [3] also reported monophasic decay, with a mean (SD) T, of 4.7 (1.1) min, in rats (n = 3) infused with SNP 100 ug mur 1 for 20 min (300 ng kg" 1 min-1 ). SNP was measured by injecting samples of the animals' blood into host rats and noting the hypotensive response. They also showed that the head, limbs, liver and kidneys in the rat each removed about 30% of the SNP from the blood passing once through their capillary beds; the lungs removed none. They concluded that the decrease in SNP resulted from rapid passage into interstitial fluid. It is possible that this mechanism is responsible for the short a-phase, whereas the P-phase, with a longer T^, may be caused by slower decomposition in the blood itself, as demonstrated by our in vitro studies [2] .
The conclusions concerning the biphasic nature of the in vivo decay of SNP based on our data, can only be tentative. Doses and duration of SNP infusions were non-uniform, leading to wide variance in the results, whilst the relatively small doses, coupled with rapid breakdown of the infused SNP, resulted in small plasma concentrations. As a consequence, although relatively large blood samples were taken, in most cases accurate measurements were not possible beyond 15 min after infusion. The volumes of blood required also placed a limit on the number of samples that could be taken and duplicate measurements were impossible. In order to obtain an accurate assessment of SNP decay, more frequent blood sampling over a long period is required. However, the close correlation between the increase in arterial pressure and the decrease in SNP concentrations would appear to confirm the validity of our results and the bi-exponential nature of SNP decay.
The close correlation between the decrease in SNP concentration and the increase in arterial pressure suggests that SNP, rather than any photochemical product produced during administration, is responsible for the hypotensive effect. As the assay has been shown not to be a source of artefactually produced HCN [2] and the infusion solutions were protected from light, the increase in free HCN during infusion must result from in vivo degradation. The close association between the decreases in plasma concentrations of HCN and SNP following infusion is a further indication of this fact. Thus, contrary to the assertions of others, SNP decomposition occurs in vivo [12] and in the plasma [13] , which reinforces our previous conclusion [2] that rigorous protection of the infusion from light does not decrease the toxic potential of SNP.
